FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367291805> ?p ?o ?g. }

• W4367291805 abstract "Even though advanced radiotherapy techniques provide a better protective effect on surrounding normal tissues, the late sequelae from radiation exposure to the heart are still considerable in breast cancer patients. The present population-based study explored the role of cox-regression-based hazard risk grouping and intended to stratify patients with post-irradiation long-term heart diseases.The present study investigated the Taiwan National Health Insurance (TNHI) database. From 2000 to 2017, we identified 158,798 breast cancer patients. Using a propensity score match of 1:1, we included 21,123 patients in each left and right breast irradiation cohort. Heart diseases, including heart failure (HF), ischemic heart disease (IHD), and other heart diseases (OHD), and anticancer agents, including epirubicin, doxorubicin, and trastuzumab, were included for analysis.Patients received left breast irradiation demonstrated increased risks on IHD (aHR, 1.16; 95% CI, 1.06-1.26; p < 0.01) and OHD (aHR, 1.08; 95% CI, 1.01-1.15; p < 0.05), but not HF (aHR, 1.11; 95% CI, 0.96-1.28; p = 0.14), when compared with patients received right breast irradiation. In patients who received left breast irradiation dose of >6,040 cGy, subsequent epirubicin might have a trend to increase the risk of heart failure (aHR, 1.53; 95% CI, 0.98-2.39; p = 0.058), while doxorubicin (aHR, 0.59; 95% CI, 0.26-1.32; p = 0.19) and trastuzumab (aHR, 0.93; 95% CI, 0.33-2.62; p = 0.89) did not. Older age was the highest independent risk factor for post-irradiation long-term heart diseases.Generally, systemic anticancer agents are safe in conjunction with radiotherapy for managing post-operative breast cancer patients. Hazard-based risk grouping may help stratify breast cancer patients associated with post-irradiation long-term heart diseases. Notably, radiotherapy should be performed cautiously for elderly left breast cancer patients who received epirubicin. Limited irradiation dose to the heart should be critically considered. Regular monitoring of potential signs of heart failure may be conducted." @default.
• W4367291805 created "2023-04-29" @default.
• W4367291805 creator A5003261770 @default.
• W4367291805 creator A5008429493 @default.
• W4367291805 creator A5013750165 @default.
• W4367291805 creator A5018448173 @default.
• W4367291805 creator A5027335652 @default.
• W4367291805 creator A5035158726 @default.
• W4367291805 creator A5041507817 @default.
• W4367291805 creator A5055939720 @default.
• W4367291805 creator A5064773904 @default.
• W4367291805 creator A5077889559 @default.
• W4367291805 creator A5078237103 @default.
• W4367291805 creator A5082737012 @default.
• W4367291805 date "2023-04-27" @default.
• W4367291805 modified "2023-09-27" @default.
• W4367291805 title "Hazard-based risk grouping effectively stratifying breast cancer patients in post-irradiation long-term heart diseases: a population-based cohort study" @default.
• W4367291805 cites W1227407856 @default.
• W4367291805 cites W1980309558 @default.
• W4367291805 cites W1984502501 @default.
• W4367291805 cites W1985967126 @default.
• W4367291805 cites W1990124576 @default.
• W4367291805 cites W1996702571 @default.
• W4367291805 cites W2022650180 @default.
• W4367291805 cites W2024799186 @default.
• W4367291805 cites W2025087036 @default.
• W4367291805 cites W2029059005 @default.
• W4367291805 cites W2050674912 @default.
• W4367291805 cites W2054509904 @default.
• W4367291805 cites W2069393038 @default.
• W4367291805 cites W2073912429 @default.
• W4367291805 cites W2074300509 @default.
• W4367291805 cites W2079442927 @default.
• W4367291805 cites W2084016080 @default.
• W4367291805 cites W2101253730 @default.
• W4367291805 cites W2108634795 @default.
• W4367291805 cites W2111008795 @default.
• W4367291805 cites W2116490529 @default.
• W4367291805 cites W2118466253 @default.
• W4367291805 cites W2122472092 @default.
• W4367291805 cites W2151585080 @default.
• W4367291805 cites W2152985493 @default.
• W4367291805 cites W2154375587 @default.
• W4367291805 cites W2154811939 @default.
• W4367291805 cites W2160677490 @default.
• W4367291805 cites W2163168145 @default.
• W4367291805 cites W2165558391 @default.
• W4367291805 cites W2165884492 @default.
• W4367291805 cites W2169281409 @default.
• W4367291805 cites W2180644401 @default.
• W4367291805 cites W2565443325 @default.
• W4367291805 cites W2600570919 @default.
• W4367291805 cites W2735238612 @default.
• W4367291805 cites W2742719453 @default.
• W4367291805 cites W2793022017 @default.
• W4367291805 cites W2807460963 @default.
• W4367291805 cites W2810146145 @default.
• W4367291805 cites W2897402727 @default.
• W4367291805 cites W2921772931 @default.
• W4367291805 cites W2989626047 @default.
• W4367291805 cites W3006438088 @default.
• W4367291805 cites W3009538365 @default.
• W4367291805 cites W3012405276 @default.
• W4367291805 cites W3026293218 @default.
• W4367291805 cites W4294605240 @default.
• W4367291805 cites W4361745827 @default.
• W4367291805 cites W95894433 @default.
• W4367291805 doi "https://doi.org/10.3389/fcvm.2023.980101" @default.
• W4367291805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37180774" @default.
• W4367291805 hasPublicationYear "2023" @default.
• W4367291805 type Work @default.
• W4367291805 citedByCount "0" @default.
• W4367291805 crossrefType "journal-article" @default.
• W4367291805 hasAuthorship W4367291805A5003261770 @default.
• W4367291805 hasAuthorship W4367291805A5008429493 @default.
• W4367291805 hasAuthorship W4367291805A5013750165 @default.
• W4367291805 hasAuthorship W4367291805A5018448173 @default.
• W4367291805 hasAuthorship W4367291805A5027335652 @default.
• W4367291805 hasAuthorship W4367291805A5035158726 @default.
• W4367291805 hasAuthorship W4367291805A5041507817 @default.
• W4367291805 hasAuthorship W4367291805A5055939720 @default.
• W4367291805 hasAuthorship W4367291805A5064773904 @default.
• W4367291805 hasAuthorship W4367291805A5077889559 @default.
• W4367291805 hasAuthorship W4367291805A5078237103 @default.
• W4367291805 hasAuthorship W4367291805A5082737012 @default.
• W4367291805 hasBestOaLocation W43672918051 @default.
• W4367291805 hasConcept C121608353 @default.
• W4367291805 hasConcept C126322002 @default.
• W4367291805 hasConcept C143998085 @default.
• W4367291805 hasConcept C164705383 @default.
• W4367291805 hasConcept C207103383 @default.
• W4367291805 hasConcept C2778198053 @default.
• W4367291805 hasConcept C2780835546 @default.
• W4367291805 hasConcept C2908647359 @default.
• W4367291805 hasConcept C44249647 @default.
• W4367291805 hasConcept C50382708 @default.
• W4367291805 hasConcept C509974204 @default.
• W4367291805 hasConcept C530470458 @default.
• W4367291805 hasConcept C71924100 @default.
• W4367291805 hasConcept C72563966 @default.

• next